Wiki-MPM
About
Browse
People
Funding
Updates
CBL and TYK2
Number of citations of the paper that reports this interaction (PubMedID
8780698
)
0
Data Source:
HPRD
(in vitro, in vivo)
CBL
TYK2
Description
Cbl proto-oncogene
tyrosine kinase 2
Image
GO Annotations
Cellular Component
Cytoplasm
Golgi Apparatus
Cytosol
Plasma Membrane
Focal Adhesion
Cilium
Membrane
Flotillin Complex
Axon
Growth Cone
Cell Projection
Membrane Raft
Perinuclear Region Of Cytoplasm
Nucleus
Cytoplasm
Cytosol
Plasma Membrane
Cytoplasmic Side Of Plasma Membrane
Membrane
Extrinsic Component Of Plasma Membrane
Extrinsic Component Of Cytoplasmic Side Of Plasma Membrane
Interleukin-12 Receptor Complex
Receptor Complex
Extracellular Exosome
Interleukin-23 Receptor Complex
Molecular Function
Phosphotyrosine Residue Binding
Ubiquitin-protein Transferase Activity
Calcium Ion Binding
Protein Binding
Zinc Ion Binding
Transferase Activity
SH3 Domain Binding
Protein Kinase Binding
Receptor Tyrosine Kinase Binding
Phosphatidylinositol 3-kinase Regulatory Subunit Binding
Cadherin Binding
Metal Ion Binding
Ephrin Receptor Binding
Ubiquitin Protein Ligase Activity
Protein Tyrosine Kinase Binding
Nucleotide Binding
Protein Kinase Activity
Protein Tyrosine Kinase Activity
Non-membrane Spanning Protein Tyrosine Kinase Activity
Growth Hormone Receptor Binding
Protein Binding
ATP Binding
Kinase Activity
Transferase Activity
Biological Process
Protein Polyubiquitination
Ubiquitin-dependent Protein Catabolic Process
Protein Monoubiquitination
DNA Damage Response
Signal Transduction
Cell Surface Receptor Signaling Pathway
Male Gonad Development
Response To Gamma Radiation
Response To Activity
Protein Ubiquitination
Cytokine-mediated Signaling Pathway
Regulation Of Signaling
Regulation Of Rap Protein Signal Transduction
Response To Testosterone
Cellular Response To Platelet-derived Growth Factor Stimulus
Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway
Response To Starvation
Negative Regulation Of Apoptotic Process
Mast Cell Degranulation
Response To Ethanol
Positive Regulation Of Epidermal Growth Factor Receptor Signaling Pathway
Symbiont Entry Into Host Cell
Positive Regulation Of Receptor-mediated Endocytosis
Protein Autoubiquitination
Positive Regulation Of Phosphatidylinositol 3-kinase/protein Kinase B Signal Transduction
Ubiquitin-dependent Endocytosis
Cellular Response To Hypoxia
Regulation Of Intracellular Signal Transduction
Cellular Response To Nerve Growth Factor Stimulus
Regulation Of Platelet-derived Growth Factor Receptor-alpha Signaling Pathway
Regulation Of Transcription By RNA Polymerase II
Protein Phosphorylation
Immune Response
Cell Surface Receptor Signaling Pathway Via JAK-STAT
Cell Population Proliferation
Cytokine-mediated Signaling Pathway
Regulation Of Cell-cell Adhesion
Cell Differentiation
Positive Regulation Of Type II Interferon Production
Positive Regulation Of Interleukin-17 Production
Positive Regulation Of Natural Killer Cell Proliferation
Intracellular Signal Transduction
Interleukin-12-mediated Signaling Pathway
Interleukin-23-mediated Signaling Pathway
Type III Interferon-mediated Signaling Pathway
Positive Regulation Of T Cell Proliferation
Regulation Of Receptor Signaling Pathway Via JAK-STAT
Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT
Regulation Of Alpha-beta T Cell Activation
Positive Regulation Of NK T Cell Proliferation
Type II Interferon-mediated Signaling Pathway
Type I Interferon-mediated Signaling Pathway
Growth Hormone Receptor Signaling Pathway Via JAK-STAT
Cellular Response To Virus
Interleukin-10-mediated Signaling Pathway
Positive Regulation Of Protein Localization To Nucleus
Positive Regulation Of T-helper 17 Type Immune Response
Pathways
Interleukin-6 signaling
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
Spry regulation of FGF signaling
Regulation of KIT signaling
EGFR downregulation
TGF-beta receptor signaling activates SMADs
Constitutive Signaling by EGFRvIII
Negative regulation of FGFR1 signaling
Negative regulation of FGFR2 signaling
Negative regulation of FGFR3 signaling
Negative regulation of FGFR4 signaling
Negative regulation of MET activity
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
Cargo recognition for clathrin-mediated endocytosis
Clathrin-mediated endocytosis
InlB-mediated entry of Listeria monocytogenes into host cell
InlB-mediated entry of Listeria monocytogenes into host cell
Regulation of signaling by CBL
Regulation of signaling by CBL
Signaling by CSF1 (M-CSF) in myeloid cells
Negative regulation of FLT3
FLT3 signaling by CBL mutants
Interleukin-6 signaling
Interleukin-6 signaling
MAPK3 (ERK1) activation
MAPK1 (ERK2) activation
Other interleukin signaling
Interleukin-10 signaling
Interleukin-4 and Interleukin-13 signaling
IL-6-type cytokine receptor ligand interactions
Interleukin-20 family signaling
Interleukin-35 Signalling
Interleukin-12 signaling
Interleukin-12 signaling
Interleukin-23 signaling
Interleukin-23 signaling
Interleukin-27 signaling
Interleukin-27 signaling
Interferon alpha/beta signaling
Regulation of IFNA/IFNB signaling
Regulation of IFNA/IFNB signaling
Signaling by CSF3 (G-CSF)
Signaling by CSF3 (G-CSF)
Potential therapeutics for SARS
Inactivation of CSF3 (G-CSF) signaling
Inactivation of CSF3 (G-CSF) signaling
SARS-CoV-2 activates/modulates innate and adaptive immune responses
Signaling by ALK fusions and activated point mutants
Evasion by RSV of host interferon responses
Drugs
2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
Ruxolitinib
Tofacitinib
Baricitinib
Fostamatinib
Abrocitinib
Deucravacitinib
Diseases
Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
GWAS
High light scatter reticulocyte count (
27863252
32888494
)
High light scatter reticulocyte percentage of red cells (
32888494
27863252
)
Mean corpuscular volume (
32888494
)
Mean spheric corpuscular volume (
32888494
)
Platelet count (
27863252
29403010
22139419
32888494
33545615
)
Plateletcrit (
27863252
32888494
)
Reticulocyte count (
27863252
32888494
)
Reticulocyte fraction of red cells (
27863252
32888494
)
Triglyceride levels (
33339817
)
Ankylosing spondylitis (
23749187
)
Autoimmune thyroid disease (
32581359
)
Autoimmune traits (pleiotropy) (
30572963
)
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) (
26974007
)
COVID-19 (critical illness vs population) (
33307546
)
Crohn's disease (
21102463
28067908
)
Inflammatory bowel disease (
28067908
23128233
)
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular) (
23603761
)
Lymphocyte count (
27863252
32888494
)
Lymphocyte percentage of white cells (
32888494
)
Medication use (thyroid preparations) (
31015401
)
Multiple sclerosis (
24076602
31604244
21833088
)
Neutrophil percentage of white cells (
32888494
27863252
)
Pediatric autoimmune diseases (
26301688
)
Platelet count (
32888494
27863252
)
Plateletcrit (
32888494
)
Primary biliary cholangitis (
26394269
)
Primary biliary cirrhosis (
22961000
)
Psoriasis (
20953190
23143594
)
Psoriasis vulgaris (
26626624
)
Psoriatic arthritis (
26626624
)
Rheumatoid arthritis (
23143596
30423114
24390342
)
Rheumatoid arthritis (ACPA-positive) (
23143596
24532676
)
Sarcoidosis (
26051272
)
Systemic lupus erythematosus (
27399966
33272962
26502338
28714469
)
Systemic lupus erythematosus or rheumatoid arthritis (
27193031
)
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies) (
30573655
)
Type 1 diabetes (
21829393
19966805
32005708
25751624
)
Voxel-wise structural brain imaging measurements in Alzheimer’s disease (
30584014
)
Interacting Genes
132 interacting genes:
ABL1
APPL1
ASAP1
AXL
BCR
BLK
BLNK
BTK
CAPN1
CBLIF
CD19
CD2AP
CD38
CD40
CD5
CDKL2
CRK
CRKL
CSF1R
CTNNB1
CUBN
CXCR5
EGFR
EIF5B
EPHA2
EPHB6
EPOR
EPS8
ETS1
F2RL1
FGR
FLOT1
FLT3
FNBP1
FRS2
FYB1
FYN
GRAP2
GRB2
HCK
IGF1R
INPPL1
INSR
ITCH
ITK
ITSN2
JAK2
KDR
KHDRBS1
KIT
KRT18
LAT
LAT2
LCK
LCP2
LRIG1
LTK
LYN
MAPK8
MET
MYH9
MYO1C
MZF1
NCK1
NECTIN1
NOTCH1
OSTF1
PDGFRA
PDGFRB
PIK3R1
PIK3R2
PLCG1
PLK1
PRKCA
PRKCQ
PTEN
PTK2B
PTPN11
PTPN22
PTPN6
RET
SCN5A
SERPINA5
SH2B2
SH3KBP1
SHC1
SLA
SLA2
SMAD7
SORBS1
SORBS2
SP7
SPRY2
SRC
STAP2
STAT3
STAT5A
STAT5B
SYK
TCN1
TCN2
TGM2
TNFRSF11A
TRAF4
TRAF6
TRIM8
TYK2
UBASH3B
UBC
UBE2D1
UBE2D2
UBE2D3
UBE2E1
UBE2E2
UBE2E3
UBE2G1
UBE2G2
UBE2L3
UBE2M
UBE2N
UBE2U
UBE2W
USP21
VAV1
VAV2
WWP1
YES1
YWHAB
YWHAG
YWHAQ
YWHAZ
ZAP70
52 interacting genes:
APOBEC3F
ARMC6
CBL
COPS5
CRKL
CYSRT1
DHX9
DNM2
EIF2AK2
FHL3
FYN
GHR
GOLGA6L9
HNRNPK
IFNAR1
IFNAR2
IL13RA1
IL6ST
IRS1
IRS2
JAK1
JAKMIP1
KHDRBS2
KHDRBS3
KRT31
KRT40
KRTAP6-3
LYN
MTTP
PDGFRB
PIK3R1
PLAUR
PRDM5
PRDX2
PRMT5
PTAFR
PTPN1
PTPN6
PTPRC
RAB11B
RACK1
SOCS1
STAM2
STAT1
STAT2
SULT1A1
TK1
TP53BP2
TRAF4
VAV1
XRCC5
ZNF177
Entrez ID
867
7297
HPRD ID
01320
01490
Ensembl ID
ENSG00000110395
ENSG00000105397
Uniprot IDs
P22681
A0A8V8TN50
A0A8V8TPX5
H0YCT7
H0YE24
P29597
PDB IDs
1B47
1FBV
1YVH
2CBL
2JUJ
2K4D
2OO9
2Y1M
2Y1N
3BUM
3BUN
3BUO
3BUW
3BUX
3OB1
3OB2
3PLF
4A49
4A4B
4A4C
4GPL
5HKW
5HKX
5HKY
5HKZ
5HL0
5J3X
5O76
6O02
6O03
6XAR
7SIY
3LXN
3LXP
3NYX
3NZ0
3ZON
4GFO
4GIH
4GII
4GJ2
4GJ3
4GVJ
4OLI
4PO6
4PY1
4WOV
5C01
5C03
5F1Z
5F20
5TKD
5WAL
6AAM
6DBK
6DBM
6NSL
6NZE
6NZF
6NZH
6NZP
6NZQ
6NZR
6OVA
6VNS
6VNV
6VNX
6VNY
6X8F
6X8G
7AX4
7K7O
7K7Q
7UYR
7UYS
7UYT
7UYU
8EXN
8EYC
8S98
8S99
8S9A
8TB5
8TB6
Enriched GO Terms of Interacting Partners
?
Cell Surface Receptor Protein Tyrosine Kinase Signaling Pathway
Cell Surface Receptor Signaling Pathway
Enzyme-linked Receptor Protein Signaling Pathway
Signal Transduction
Protein Tyrosine Kinase Activity
Immune Response-regulating Cell Surface Receptor Signaling Pathway
Immune Response-activating Cell Surface Receptor Signaling Pathway
Regulation Of Immune Response
Immune System Process
Immune Response-regulating Signaling Pathway
Regulation Of Immune System Process
Antigen Receptor-mediated Signaling Pathway
Positive Regulation Of Immune System Process
Peptidyl-tyrosine Phosphorylation
Immune Response-activating Signaling Pathway
Phosphotyrosine Residue Binding
Regulation Of MAPK Cascade
Regulation Of Intracellular Signal Transduction
Positive Regulation Of Immune Response
Positive Regulation Of Intracellular Signal Transduction
Plasma Membrane
Activation Of Immune Response
Cell Activation
Leukocyte Activation
Positive Regulation Of MAPK Cascade
Protein Kinase Activity
Intracellular Signal Transduction
Regulation Of Signal Transduction
Lymphocyte Activation
Non-membrane Spanning Protein Tyrosine Kinase Activity
ATP Binding
Fc Receptor Signaling Pathway
Positive Regulation Of Phosphatidylinositol 3-kinase/protein Kinase B Signal Transduction
Transferase Activity
Positive Regulation Of Signal Transduction
Regulation Of Cell Adhesion
Kinase Activity
Regulation Of Signaling
Regulation Of Cell Communication
Protein Modification Process
Positive Regulation Of Cell Adhesion
Positive Regulation Of Cell Communication
Positive Regulation Of Signaling
Regulation Of Cell Activation
Regulation Of Lymphocyte Activation
Cell Migration
Protein Phosphorylation
Phosphorylation
Nucleotide Binding
Transmembrane Receptor Protein Tyrosine Kinase Activity
Cytokine-mediated Signaling Pathway
Cell Surface Receptor Signaling Pathway Via JAK-STAT
Cell Surface Receptor Signaling Pathway
Cell Surface Receptor Signaling Pathway Via STAT
Positive Regulation Of Signal Transduction
Phosphotyrosine Residue Binding
Growth Hormone Receptor Signaling Pathway
Regulation Of Apoptotic Process
Positive Regulation Of Cell Communication
Positive Regulation Of Signaling
Regulation Of Signal Transduction
Positive Regulation Of Intracellular Signal Transduction
Regulation Of Intracellular Signal Transduction
Regulation Of Programmed Cell Death
Positive Regulation Of Multicellular Organismal Process
SH3 Domain Binding
Cell Surface Receptor Protein Tyrosine Kinase Signaling Pathway
Regulation Of Receptor Signaling Pathway Via JAK-STAT
Growth Hormone Receptor Signaling Pathway Via JAK-STAT
Receptor Complex
SH2 Domain Binding
Response To External Biotic Stimulus
Cytokine Binding
Phosphatidylinositol 3-kinase Binding
Regulation Of Phosphatidylinositol 3-kinase/protein Kinase B Signal Transduction
Enzyme Binding
Response To Peptide Hormone
Regulation Of Signaling
Regulation Of Cell Communication
Enzyme-linked Receptor Protein Signaling Pathway
Signal Transduction
Cytosol
Regulation Of MAPK Cascade
Cellular Response To Insulin Stimulus
Cellular Response To Platelet-derived Growth Factor Stimulus
Regulation Of Cell Adhesion
Type I Interferon-mediated Signaling Pathway
Response To Other Organism
Response To Insulin
Insulin Receptor Binding
Positive Regulation Of Cell-cell Adhesion
Response To Platelet-derived Growth Factor
Regulation Of Defense Response
Protein Kinase Binding
Phosphatidylinositol 3-kinase Activator Activity
Cellular Response To Peptide Hormone Stimulus
Lymphocyte Proliferation
Ephrin Receptor Binding
Mononuclear Cell Proliferation
Regulation Of Macromolecule Biosynthetic Process
Tagcloud
?
Tagcloud (Difference)
?
Tagcloud (Intersection)
?